Literature DB >> 15274192

Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle.

Prerana Patel1, Wen-Ning Qi, Diane M Allen, Long-En Chen, Anthony V Seaber, Jonathan S Stamler, James R Urbaniak.   

Abstract

This study examined the effects of 1400W, an inhibitor of inducible nitric oxide (iNOS), on contractile function and iNOS expression in reperfused skeletal muscle. The right extensor digitorum longus (EDL) muscle of 104 rats underwent a sham operation or 3-h ischemia followed by 3-h or 24-h reperfusion (I/R). Rats received 3 mg/kg 1400W, 10 mg/kg 1400W, or water subcutaneously. Results showed that EDL contractile function in both 1400W-treated groups significantly outperformed the controls at 24-h but not at 3-h reperfusion. Although iNOS expression increased in all three I/R groups during reperfusion, a significantly smaller increase was found in 1400W-treated muscles after 3-h reperfusion, and more dramatically so after 24-h reperfusion. Our results indicate that inhibition of iNOS preserved the contractile function in reperfused skeletal muscle, perhaps via downregulating iNOS expression. Protection by 1400W at 24-h reperfusion suggests that the role of iNOS in exaggerating reperfusion injury is more prominent in the later stages of injury. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274192     DOI: 10.1002/micr.20029

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  6 in total

1.  Homocysteine disrupts outgrowth of microvascular endothelium by an iNOS-dependent mechanism.

Authors:  Jamie N Mayo; Cheng-Hung Chen; Francesca-Fang Liao; Shawn E Bearden
Journal:  Microcirculation       Date:  2014-08       Impact factor: 2.628

2.  Effect of 1400W on blocking lipopolysaccharide-induced microglial toxicity to preoligodendrocytes.

Authors:  Ya-Fang He; Hui-Jin Chen; Long-Huan Qian; Guan-Yi Chen
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

3.  Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.

Authors:  Robert S Crawford; Hassan Albadawi; Marvin D Atkins; John E Jones; Hyung-Jin Yoo; Mark F Conrad; W Gerald Austen; Michael T Watkins
Journal:  Surgery       Date:  2010-02-04       Impact factor: 3.982

4.  Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS Expression.

Authors:  Lei Pang; Yin Cai; Eva Hoi Ching Tang; Dan Yan; Ramoji Kosuru; Haobo Li; Michael G Irwin; Haichun Ma; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2016-10-04       Impact factor: 6.543

5.  nNOS-derived NO modulates force production and iNO-derived NO the excitability in C2C12-derived 3D tissue engineering skeletal muscle via different NO signaling pathways.

Authors:  Matias Mosqueira; Lisa-Mareike Scheid; Dominik Kiemel; Talisa Richardt; Mona Rheinberger; Dirk Ollech; Almut Lutge; Tim Heißenberg; Lena Pfitzer; Lisa Engelskircher; Umut Yildiz; Isabel Porth
Journal:  Front Physiol       Date:  2022-08-15       Impact factor: 4.755

6.  Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation.

Authors:  Paola Palumbo; Francesca Lombardi; Giuseppe Siragusa; Soheila Raysi Dehcordi; Sabino Luzzi; AnnaMaria Cimini; Maria Grazia Cifone; Benedetta Cinque
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.